S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Putin orders 'large-scale' COVID-19 vaccination in Russia

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Russian President Vladimir Putin attends a meeting via video conference at the Novo-Ogaryovo residence outside Moscow, Russia, Wednesday, Dec. 2, 2020. Russian President Vladimir Putin announced start of large-scale vaccination of medics and teachers against COVID next week. Speaking during an online meeting dedicated to inauguration of new hospitals for coronavirus patients built by Russian Defense Ministry, Putin said Russia has enough capacity to start "large-scale" vaccination of teachers and doctors. (Alexei Nikolsky, Sputnik, Kremlin Pool Photo via AP)

MOSCOW (AP) — President Vladimir Putin on Wednesday ordered a “large-scale” COVID-19 immunization campaign to start by late next week, with doctors and teachers set to be first in line to get a Russian-designed vaccine that has yet to complete the advanced studies needed to ensure its effectiveness and safety in line with established scientific protocols.

Putin’s action came hours after Britain became the first country in the West to authorize the use of a vaccine against the coronavirus developed by U.S. drugmaker Pfizer and Germany’s BioNTech.

Russia touted its domestically developed vaccine, Sputnik V, as the world’s “first registered COVID-19 vaccine” after the government gave it regulatory approval in early August. However, giving the shots the go-ahead drew considerable criticism from experts, because at the time the Sputnik V only had been tested on several dozen people.

The Russian leader said at the time that the early vaccine recipients included one of his daughters.

Putin said Wednesday that more than 2 million doses of the Sputnik V jab “has been produced or will have been produced in the next few days.”

“This gives us the opportunity to start if not mass, but large-scale vaccination, and of course, as we agreed, first of all of the two risk groups — doctors and teachers,” Putin told government officials. He tasked Deputy Prime Minister Tatyana Golikova to “organize the work in such a way so that large-scale vaccination starts by the end of next week."

Golikova said that the shots will be voluntary and free of charge, and that the government was looking to include other demographic groups in the vaccination campaign.

The two-shot Sputnik V vaccine was developed by the Moscow-based Gamaleya Institute. An advanced study among 40,000 volunteers was announced two weeks after the vaccine received government approval. The trial is still ongoing.


But the vaccine is already being offered to people in high risk groups such as medical workers, despite expert warnings against its wider use before all the necessary testing is done. Several high-profile officials have said they received jabs.

Health Minister Mikhail Murashko said Wednesday that more than 100,000 people in Russia have been given the shots.

Kirill Dmitriyev, head of the Russian Direct Investment Fund that bankrolled Sputnik V's development, added that around 25,000 people have been vaccinated with both doses of the vaccine “as part of a clinical trial now.” Dmitriyev said that outside of the trial, the vaccine was offered to “volunteers” among medical workers “because we wanted to protect our frontline personnel first.”

Last month, developers of the vaccine said interim analysis of trial data showed it was 91.4% effective. The conclusion was based on 39 infections among 18,794 study participants that received both doses of either the vaccine or a placebo, which is a much lower number of infections than Western drugmakers have looked at when assessing the effectiveness of their vaccines.

Dmitriyev said Wednesday that developers of the vaccine have applied to the European Medicines Agency to get Sputnik V approved for use in Europe, and submitted applications in other countries.

“We understand that it may take some time, but we concurrently, you know, have applied for approval in 40 different countries and we are working very closely with regulators in all of those countries," Dmitriyev said.

Dmitriyev said last month that more than 1 billion doses of the vaccine were expected to be produced next year outside of Russia. Putin's spokesman, Dmitry Peskov, however, stressed Wednesday that vaccinating Russians “will be the absolute priority."

Russia has been swept by a rapid resurgence of the outbreak this fall, with numbers of confirmed COVID-19 infections and deaths regularly hitting new highs and significantly exceeding those reported in the spring.

On Wednesday, Russia reported a record high daily number of coronavirus deaths, 589. The previous record of 569 deaths was registered on Tuesday. The government task force has recorded a total of 41,053 virus-related deaths since the start of the outbreak.

Russia’s total of over 2.3 million confirmed cases is currently the fourth-largest caseload in the world. On Wednesday, officials reported 25,345 new cases.

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Pfizer right now?

Before you consider Pfizer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.

While Pfizer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Pfizer (PFE)
4.991 of 5 stars
$25.99+2.4%6.46%72.19Hold$36.88
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

7 Stocks to Help You Build Off January’s Gains

7 Stocks to Help You Build Off January’s Gains

It's frequently said that as January goes, so goes the market. If that's the case, it's time for investors to put money to work in the stock market.

Search Headlines: